tirzepatide and semaglutide injections vs Semaglutide: What's the Difference? Troubling Findings in Study of

All treatments are non-invasive, medically supervised, and customized to fit your comfort and pace.

New Hampshire Medicaid dropped GLP-1 obesity coverage effective January 1, 2026

However, hair loss doesn't appear on the official list

Additionally, medications that suppress the immune system, like corticosteroids or chemotherapy drugs, can also make kidney infections more likely

You are not a candidate for GLP-1 medications through our program if you are, or have a history of: Pancreatitis Thyroid cancer or multiple endocrine neoplasia syndrome (whether yourself or a first-degree relative) Currently pregnant or trying to become pregnant Crohns disease Gastroparesis, or have had a gastric bypass, gastric band, or gastric sleeve surgery Your safety is our top priority, and we carefully evaluate all patients to ensure the best treatment plan

Available as once-weekly injectable (Ozempic/Wegovy) and once-daily oral tablet (Rybe